In one paragraphArticle in Journal of comparative effectiveness research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Tatiana FiordelisioLaboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia, Facultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Alcaldía Coyoacán, Ciudad de México, México.ORCID 0000-0002-9282-1476 Francisco Valdés-SoutoFacultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Alcaldía Coyoacán, Ciudad de México, México.ORCID 0000-0001-6736-0666 Diana Del-Rio ValdesLaboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia, Facultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Alcaldía Coyoacán, Ciudad de México, México.ORCID 0000-0002-7587-0866 Diego Zamarrón HernándezLaboratorio Nacional de Soluciones Biomiméticas para Diagnóstico y Terapia, Facultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Alcaldía Coyoacán, Ciudad de México, México.ORCID 0000-0002-8315-5504 Karla Ramírez PulidoFacultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Alcaldía Coyoacán, Ciudad de México, México.ORCID 0000-0003-2953-9467 Cristopher Alejandro Escamilla SotoFacultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Alcaldía Coyoacán, Ciudad de México, México.ORCID 0009-0006-9688-0576 Yair Uriel Correa TrejoFacultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Alcaldía Coyoacán, Ciudad de México, México.ORCID 0009-0008-9611-9888 Claudia Itzel Gutiérrez SánchezFacultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Alcaldía Coyoacán, Ciudad de México, México.
Isabel Espino GutiérrezFacultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Alcaldía Coyoacán, Ciudad de México, México.
Claudia Haydeé Arce SalinasDepartamento de Oncología Médica, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, Ciudad de México, México.ORCID 0000-0001-9860-3739 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antineoplastic Agents, ImmunologicalBreast NeoplasmsTrastuzumabAdultFemaleHospitals, PublicHumansInfusions, IntravenousInjections, SubcutaneousMexicoMiddle AgedPatient SatisfactionProspective StudiesTime and Motion StudiesAntineoplastic Agents, ImmunologicalTrastuzumabbreast cancerreal-world evidencesubcutaneous vs intravenoustime-and-motion studytrastuzumab
Identifiers
PMID42003708
PMCPMC13154924
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390